Syntheses and applications of enantiopure δ-amino acids and their precursors by Stendall, Ryan T. & Cobb, Alexander J.A.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1016/j.tet.2018.05.034
Document Version
Peer reviewed version
Link to publication record in King's Research Portal
Citation for published version (APA):
Stendall, R. T., & Cobb, A. J. A. (2018). Syntheses and applications of enantiopure -amino acids and their
precursors. TETRAHEDRON. https://doi.org/10.1016/j.tet.2018.05.034
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 09. Jul. 2020
Accepted Manuscript
Syntheses and applications of enantiopure δ-amino acids and their precursors
Ryan T. Stendall, Alexander J.A. Cobb
PII: S0040-4020(18)30567-2
DOI: 10.1016/j.tet.2018.05.034
Reference: TET 29541
To appear in: Tetrahedron
Received Date: 1 March 2018
Revised Date: 10 May 2018
Accepted Date: 11 May 2018
Please cite this article as: Stendall RT, Cobb AJA, Syntheses and applications of enantiopure δ-amino
acids and their precursors, Tetrahedron (2018), doi: 10.1016/j.tet.2018.05.034.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all
legal disclaimers that apply to the journal pertain.
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Graphical Abstract 
To create your abstract, type over the instructions in the template box below. 
Fonts or abstract dimensions should not be changed or altered. 
Syntheses and Applications of Enantiopure 
δ-Amino Acids and their Precursors 
Ryan T. Stendall and Alexander J. A. Cobb* 
Department of Chemistry, King’s College London, 7 Trinity Street, London SE1 1DB 
 
 
Leave this area blank for abstract info. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 1 
 
 
Tetrahedron 
journal  homepage:  www.e lsevier .com  
 
Syntheses and Applications of Enantiopure δ-Amino Acids and their Precursors 
Ryan T. Stendall and Alexander J. A. Cobb* 
Department of Chemistry, King’s College London, 7 Trinity Street, London SE1 1DB, United Kingdom 
 
In recognition of the astonishing accomplishments and contributions to chemistry of Professor Sir Derek H. R. Barton FRS FRSE  
 
1. Introduction 
Unnatural peptidic amino acids (Figure 1a) have 
unsurprisingly been the subject of vigorous study for a very long 
time. For obvious reasons, their similarity to native amino acids 
mean that they can participate in a range of biological 
interactions either as discrete molecules in themselves, or as a 
part of an unnatural peptide. Unnatural α-Amino acids are, as one 
might expect, the largest representative class of molecule in this 
area,
1
 but in more recent years β- and γ-amino acids have become 
of increasing interest. A major reason for the lag in the number of 
reports for these homologated systems is the difficulty in 
accessing stereogenically pure frameworks – the importance of 
such purity is of course self-evident. The stereoselective 
synthesis of β-amino acids and γ-amino acids have been the 
subject of other reviews which also detail their applications,2,3 
and we ourselves have contributed to the latter.4 δ-Amino acids 
on the other hand have not had the same level of scrutiny, which 
is somewhat surprising given that they are essentially dipeptide 
mimics (Figure 1b). This review therefore seeks to examine the 
methods that have been employed towards their stereoselective 
synthesis and to highlight some of their notable applications.3b 
For the purposes of simplicity, only systems whereby there are 
no fewer than four carbon atoms between the  C- and N-termini 
(or their immediate precursors) within the shortest route are 
considered. The nomenclature used is as per convention whereby 
the superscripted number(s) after the “δ” describe the positions of 
substitution (Figure 1c). 
 
2. Synthesis via Chiral Pool Molecules 
Perhaps the most obvious way to synthesize extended amino 
acids is to homologate existing stereogenically pure systems – 
normally the corresponding α-amino acid. An early example of 
this came from the group of Kaltenbronn who were developing a 
range of renin inhibitors containing dipeptide mimetics.5 Starting 
from the amino acid derived aldehyde 1, homologation using 
Wittig reagent 2 gave a separable mixture of alkenes 3. 
Subsequent selective hydroboration of the alkyne in this system 
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Figure 1 : (a) An α-amino acid and homologated variants (b) An α-dipeptide 
has the same number of atoms between the two termini as a monomeric δ-
amino acid (c) A brief guide to the simple nomenclature of homologated amino 
acids
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2
followed by reduction gave the Boc-protected δ5-amino acid 5 
(Scheme 1). 
 
 
Another example of this type of homologation approach 
comes from the work of Déziel and co-workers who accessed a 
range of δ-amino acids by homologation of the corresponding α-
amino acids.6 This was achieved through conversion of the 
methyl ester protected C-terminus into the corresponding β-
ketophosphonate 7 which could then undergo Horner-
Wadsworth-Emmons reaction with benzylglyoxylate 8 to give 
the protected δ5-amino acid 9 (Scheme 2). 
 
A similar approach was taken by Luthman and co-worker in 
their synthesis of δ-amino acid systems with two stereogenic 
centres (Scheme 3).7 In this work, they synthesized phosphonium 
salt 11 in three steps from (S)-phenylalinol 10 in overall 92% 
yield. The next Wittig stage was performed using (R)- or (S)-12, 
as access to both epimers was required. However, the 
enantiomeric purity of the aldehydes used was only 82 and 84% 
for (R)- and (S)-enantiomers respectively as they were accessed 
using either lipase-catalysed desymmetrisation or resolution as 
key steps (see section 3), meaning that the diastereomeric purity 
of the final δ-amino acids was compromised.  
 
Nevertheless, both Déziel and Luthman’s homologation 
approaches were used to good effect by Linusson and Kihlberg 
who developed a range of isosteric glycopeptides aimed at 
investigating the binding of the CII259-270 glycopeptide 14 to 
the arthritis-associated murine Aq class II major 
histocompatibility complex (MHC) protein.8 In this study, the 
authors wished to investigate the effect of removing hydrogen-
bonding possibilities from the glycopeptide on binding. They 
achieved this by using δ-amino acids to strategically replace 
various dipeptide units within the glycopeptide (Figure 2). 
 
Based on several earlier studies by Yamamoto, Taga, Ibuka 
and Fujii,9 alongside work by Wipf,10 another Wadsworth-
Emmons homologation approach was utilised by Fujii himself 
and co-workers in their investigation of dipeptide isosteres aimed 
at developing agonists of GPR54 a Gq-protein-coupled receptor 
linked to antimetastatic activity.11 Access to the δ2-amino acid 20 
itself was achieved through the stereoselective copper mediated 
anti-SN2’ ring-opening of an aziridine which was derived from D-
serine 17 (Scheme 4).9a,10 
BocHN CHO
Ph3P
TMSBr
nBuLi BocHN
TMS
(cychex)2BH
H2O2 BocHN
O
OH
H2 (1 atm)
Pd/C
BocHN
O
OH
1
2
3
4 5
Scheme 1 : Kaltenbronn's δ5-amino acid synthesis via homolgation of an α-amino acid 
derived aldehyde
H2N
OH
1) (CF3CO)2O, NEt3
0 oC, CH2Cl2, 93%
2) CBr4, PPh3
0 oC, MeCN, 85%
3) PPh3, PhMe
reflux, >99%
N
H
PPh3
O
F3C
Br
 
nBuLi (2 eq)
THF, -78 oC then
H
O
OTBS
N
H
O
F3C OTBS
10 11
12
13
Scheme 3 : Luthman's synthesis of a δ2,5-amino acid dipeptidomimetic with 
two stereocentres
O
OH OH
O NH2
O
Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr273N
H
Gly259-Ile-Ala-Gly-Phe
HO
OH
Glycopeptide 14 (CII259-273)
O
OH
R2
R1
FMocHN
O
OH
R2
R1
FMocHN
a : R1  = iBu, R2 = Me
b : R1  =Me, R2 = H
c : R1  = H, R2 = Bn
15 16
Figure 2 : Glycopeptide 14  with the amino acids targeted for dipeptide 
bioisosteric replacement highlighted
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A different homologation of α-amino acids was used by 
Eskici and co-workers in the formal synthesis of (S)-coniine 26, 
who converted L-norvaline derived β-amino alcohol 21 into the 
correseponding cyclic sulfamidate 22.12 This underwent reaction 
with lithium acetylide 23 to generate intermediate orthoester 24, 
which under acidic conditions gave δ5-amino ester 25. 
Thereafter, (S)-coniine was obtained over a few simple steps 
(Scheme 5). 
 
Seebach and co-workers utilized a Grignard homologation 
process in their synthesis of gem-difluoro dipeptide isosteres 
(Scheme 6).13 Starting with homovaline derivative 27, the 
aforementioned Grignard reaction with 2-phenylethyl magnesium 
bromide gave the non-chelation controlled β-amino alcohol in a 
12:1 dr. Swern oxidation to the ketone followed by DAST 
fluorination gave the gem-difluoro compound 30. Interestingly, 
during this procedure the DAST also removed one of the benzyl 
groups, which the authors suggest occurs via an aziridinium 
intermediate followed by SN2 displacement of one of the benzyl 
groups. The authors then incorporated this dipeptidomimetic into 
angiotensin analogue 33 to give mimetic 34 in an attempt to find 
a renin inhibitor (Figure 3). Although no inhibition was observed, 
this was the only peptide to be tested, and further investigations 
are worthy of attention. 
 
 
δ-Amino acids derived from sugars have also been reported. 
For example, Kessler and co-workers14 used the glucosamine 
derived δ-amino acid 35 (first synthesized by Heyns and 
Paulsen15) as a D-Ser-Ser mimic (Figure 4). 
 
δ-Ribose derived δ-amino acids were developed by Fleet and 
co-workers towards the attempted synthesis of foldamers.16 
Described as a “branched-δ-THF”, these systems were 
synthesized from the protected D-ribonolactone 36 by SN2 
displacement with azide – the precursor to the N-terminus. 
Reduction of this compound to the lactol, followed by aldol 
reaction with formaldehyde and selective oxidation of hemiacetyl 
hydroxyl introduced the 2’-hydroxymethyl substituted system 40. 
Treatment with HCl and methanol removed the acetal  and 
formed the methyl ester  along with cyclization onto the triflate 
by the resulting secondary alcohol to give  42. This was then 
used to form the unnatural δ-peptide 43.
H2N
O
OH
OH
17
1) SOCl2, MeOH
2) MtsCl, NEt3
3) PPh3, DEAD
N
CO2Me
Mts
18
1) DIBAL-H, 78 oC
2) (ArO)2P(O)CH2CO2tBu
NaI, DBU, -78 oC N
Mts
19
CO2tBu
iBuCu(CN)MgCl.LiCl
-78 oC MtsHN CO2
tBu
20
Scheme 4 : Fujii's synthesis of a dipeptide analogue aimed 
at GPR54 agonism
BnHN OH
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1) SOCl2, imidazole
NEt3, CH2Cl2
2) NaIO4, Ru(cat)
MeCN:H2O HN
S OO
O
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23
THF, -10 oC
BnHN
nPr
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OEt
OEt
24
5M HCl
then NaHCO3 BnHN
nPr OEt
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O
HN
nPr
(S)-coniine 26
Scheme 5 : Eskici's synthesis of (S)-coniine 26 via a δ5-amino ester
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4 d
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F
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Scheme 6 : Seebach's gem-difluoro-δ5-amino acid synthesis
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Figure 3 : Seebach's peptidomimetic of an angiotensin analogue
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N
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D L
Figure 4 : Kessler and co-workers have shown that 
glucosamine derived amino acids 35 has a similar conformation 
to a D-Ser-Ser dipeptide and as such is a good mimic for it.
35
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Sharma and co-workers have also utilized carbohydrate derived 
systems as frameworks for δ-amino acids.17 In this work, 
homologation of aminosugar 45 – itself synthesized by a Michael 
addition of benzylamine to conjugated ester 4418 gave 
unsaturated δ5 amino acid 47. These systems were then utilized in 
the study of α/δ-hybrid peptides as novel foldamers.19 
 
3. Synthesis via Resolution Methods 
An alternative method of accessing enantiopure δ-Amino 
Acids is to resolve the desired enantiomer from a racemic 
mixture formed at some stage in the synthesis. This can be 
achieved through either kinetic (relying on the different chemical 
properties of racemic starting materials) or chiral (relying on the 
different physical properties of diastereomeric products) 
resolution.  
As an example of the former, Mantelingi, Rangappa and co-
workers have made a range of proline derivatives via a δ-amino 
acid precursors.20 The first stereocentre was installed via an 
enzymic resolution of a racemic γ-aminoalcohol (±)-49, itself 
made from methyl methacrylate 48 (Scheme 9). This was 
achieved using Pseudomonas capacia in the presence of vinyl 
acetate to generate the desired intermediate (S)-49 with 90% 
enantiomeric excess. Homologation by oxidation and Wittig 
reactions (as used in the approaches above), gave the 
corresponding δ-amino acid precursor 50. This system was 
further functionalized by a catalytic dihydroxylation to generate 
the vicinal diol 51 in an 80% yield and an enantiomeric excess of 
96% before ultimately being converted to the desired proline 
derivative 52. 
 
Similarly, Hunter and co-workers made protected α,β,γ-
trifluoro-δ-amino acid 5921 by first using the highly reactive 
polymer supported lipase Novozyme 435 according to the work 
of Kočovský and co-workers22 to resolve an aryl allylic alcohol 
53. The resulting enantiopure system was homologated by cross 
metathesis with N-allylphthalimide using Grubbs 2nd generation 
catalyst to give the δ-amino acid precursor 54 (Scheme 10). As 
with the above example subsequent stereocentres were 
introduced using a catalytic asymmetric process. In this case a 
Sharpless Asymmetric Epoxidation gave the resulting epoxide in 
94% yield and >99:1 dr. Fluorination with bis(2-
O O
HO
O O
Ribonolactone 36
Tf2O, pyridine
CH2Cl2 then
NaN3, EtOAc
O O
N3
O O
37
DIBAL-H
CH2Cl2
-78 oC
O OH
N3
O O
38
CH2O
K2CO3
H2O
O OH
N3
O O
39
OH
Br2
BaCO3
H2O
O O
N3
O O
OH
40
Tf2O
pyridine
CH2Cl2
O O
N3
O O
OTf
41
HCl
MeOH
O
N3
OH
OH
CO2Me
O
N3
OH
OH
O
O
HN
OH
OH
O
O
NH
OH
OH
CO2Me
n
n=0,2,4,6
42
43
Scheme 7 : Fleet's D-ribose derived δ-amino acid and corresponding foldamer
O
HO O
O
O
MeO
BnNH2
nBuLi, THF
-40 oC
O
HO O
O
O
MeO
H
BnHN
44 45
O
HO O
O
O
H
BocHN
46
Ph3P
O
OEt
MeOH, 0 oC
O
HO O
O
H
BocHN
47
O
EtO
H
Scheme 8 : Sharma and coworkers' access to a carbohydrate δ-amino acid, 
accessed by homologation of a β-amino acid
Me
O
Me
48
3 steps
Ref 20 OH
NBn Boc
Me
rac-49
vinyl acetate
P. capacia
47%
OH
NBn Boc
Me
(S)-49
ee : 90%
NBn Boc
Me
O
OEt AD-mix-β
Yield : 80%
ee : 96%
50
NBn Boc
Me
O
OEt
51
OH
OH
N
Bn
OHMe
CO2H
Scheme 9 : Mantelingi and Rangappa's synthesis of proline derivatives 
proceeds via a δ-amino acid where the initial stereocentre is installed by an 
enzymic kinetic resolution
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methyoxyethyl)amino sulfur trifluoride (DeoxyFluor) gave 
compound 56 in 94% yield and >99:1 dr. Treatment of this with 
neat trimethylamine trihydrofluoride under microwave conditions 
and a second treatment with DeoxyFluor gave the trifluoro 
compound 57. The C-terminus was generated by the oxidative 
degradation of the aromatic ring to give the desired δ-amino acid 
precursor 59. 
 
A prominent example of chiral resolution was given by Hall 
and co-workers in the synthesis of piperidine-derived γ-secretase 
modulators - compounds with therapeutic potential for the 
treatment of Alzheimer’s disease.23 In this work, deprotonation of 
pyridine 60 and trapping with dimethylcarbonate gave ester 61. 
Subsequent reduction of this gave the racemic cis-piperidine. 
Chiral resolution – conducted first by crystallisation with L-
mandelic acid where the formed salt (containing the unwanted 
piperidine enantiomer) was filtered off, followed by 
crystallisation from the filtrate using D-mandelic acid gave the 
desired enantiomerically pure piperidine 62, the absolute 
configuration of which was confirmed via X-ray crystallographic 
analysis. With the required stereochemistry now in place, the 
successful synthesis of target compound 63 completed in a total 
of 7 steps (Scheme 11). 
 
Chiral resolution was also utilised by Mark Bunnage and his 
co-workers at Pfizer in the synthesis of a series of novel 
imidazolepropionic acids - compounds that were projected to 
possess antithrombotic potential.24 In this approach, Boc-
protected piperidinone 64 was deprotonated using LHMDS and 
the resultant enolate treated with carboxaldehyde 65 to give 
product 66. This was then catalytically hydrogenated using 
palladium-black, forming a racemic product, which was resolved 
via chiral high-performance liquid chromatography to yield 67 as 
a single enantiomer in 36% yield (out of a maximum 50%). The 
target imidazolepropionic acid compound could then be 
synthesised, firstly via a ring-opening reaction facilitated by mild 
lithium hydroxide conditions, an acid hydrolysis and finally ion-
exchange chromatography to give δ2-amino acid 68 in ≥95% 
enantiomeric excess (Scheme 12). 
 
4. Synthesis via Chiral Auxiliaries 
Since their introduction in the 1970’s, chiral auxiliaries have 
become a common method of controlling the stereochemical 
outcome of reactions and represent a viable option in the 
synthesis of extended amino acids. An early example of such an 
approach is given by Wilson and co-workers as part of their work 
N
CF3
60
 LDA, THF
dimethylcarbonate 
-70 oC, 89%
N
CF3
O
O
61
HN
CF3
O
O
1) PtO2, 4M HCl in dioxane, 
MeOH, H2, 50 oC, ca 3 atm, 
3h, 99%
2) L-mandelic acid, 
i-PrOH, filtration 
3) D-mandelic acid,
 i-PrOH, 38%
N
CF3
O
O
NF3C
Scheme 11 : Hall's chiral resolution via crystallisation of a piperidine ester aimed at the 
treatment of Alzheimer's
6263
NBoc
O
LHMDS, THF
-78 oC
N
N
N
N NBoc
O
1) Pd black, H2, EtOH, 
4 atm, 60 oC, 18h N
N
nPr
NBoc
O
1) aq. LiOH, THF, rt, 18h
2) aq. HCl, rt, 4h
3. Dowex 50WX8-20, 
H2O/NH3 (97:3)
N
N
nPr
OH
O
NH2
64
65
66
68
ee : 95%
Scheme 12 : Bunnage and co-workers' resolution via chiral HPLC
2) chiral HPLC resolution,
DCM/MeOH (97:3)
nPr
nPr
Yield : 36%
ee : >95%
O
67
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to synthesise peptide based inhibitors of interleukin-8 using an 
unnatural δ2-amino acid within the sequence.25 The Evans’ chiral 
auxiliary (S)-4-benzyl 2-oxazolidinone was reacted with 
propionyl chloride to generate compound 71. Acrylonitrile was 
then introduced in a stereoselective manner, forming Michael 
adduct 72. Removal of the auxiliary and reduction of the nitrile 
under pressure, gave δ2-amino acid 73 (Scheme 13). Mosberg 
also used this strategy in the synthesis of conformationally 
restricted peptidic analogs of the direct thrombin inhibitor FM 
19.26 
 
The enantiomer of compound 73 was required by the Dix 
group as isosteres of arginine and lysine for use as N-terminal 
capping residues.27 Their synthesis of it only differed slightly in 
that they swapped the partner that was attached to the auxiliary.  
 
Linusson, Kihlberg and co-workers also utilized an auxiliary 
approach to their work described earlier in this review.8b 
Oxizolidinone 78 was alkylated with benzyl bromide in the 
presence of LDA to afford intermediate 79 in a 93:7 
diastereomeric ratio – ultimately leading to the desired N-Fmoc 
protected δ2-amino acid system (Scheme 15). 
 
Fustero, Barrio and co-workers employed an N-sulfinyl imine 
auxiliary in their synthesis of a δ-amino acid indane.28 Treatment 
of system 82 with CF3TMS/TBAT gave the corresponding 
Michael adduct in good yield and excellent diastereoselectivity. 
Reduction  of the N-sulfinyl imine bond of the product with 
sodium borohydride gave the syn-δ3,5-amino acid with similarly 
excellent diastereoselectivity. Removal of the auxiliary with HCl 
then gave the corresponding δ-aminoester in very good yield. 
(Scheme 16). 
 
Finally, as δ-lactams can be hydrolysed to the corresponding 
δ-amino acid (as seen in Scheme 12), their asymmetric alkylation 
provides a potential route to enantiopure systems. A notable 
example of this is presented by Enders and co-workers using 
hydrazide chiral auxiliaries (Scheme 17).29 Lactam 87 was 
formed by the cyclization of chloroalkano hydrazide 86, which 
already bears the required chiral auxiliary (SEP shown at bottom 
of Scheme 17). This was then lithiated by treatment of LDA, 
followed by the addition of the appropriate propionic acid 
Michael acceptor to form the substituted lactam 88 to a high 
diastereomeric excess. Subsequent saponification of the ester 
group and removal of the chiral auxiliary gave the final lactam 
product 89 with an enantiomeric excess of 92%. 
NHO
O
Bn69
+ Cl
O
70
nBuLi
THF
-78 oC to rt
14h, 93%
NO
O
Bn
O
71
acrylonitrile
TiCl3(OiPr)
DIEA
0 oC
4h, 94%
NO
O
Bn
O
Me
72 CN
1) aq. LiOH
rt, 15h
2) H2, PtO2
aq MeOH
14 h, 92%
HO
O
NH2
Me
73
Scheme 13  : Wilson's synthesis of δ-amino acid components of peptides aimed at 
inhibition of interleukin-8
N3 OH
O
1) NEt3, tBuCOCl
2) nBuLi, 
chiral auxiliary 69
N3
O
N O
O
1) KHMDS
2) MeI, AcOH N3
O
N O
O 1) H2O2, LiOH
2) H2, Pd/C
Me
H2N OH
O 2.0 M NaOH, 
S-methylthiourea N
H
OH
O
74 75
76
77
Bn
Bn
Scheme 14: Dix's synthesis of a δ-amino acid via the use of a chiral auxiliary
NH
H2N
ent-73
NPh
Ph O
N O
O
Me Ph
BnBr
LDA
-78 oC to 0 oC
Yield : 70%
dr 97:3
NPh
Ph O
N O
O
Me Ph
Ph
78 79
FMocHN
O
OH
Ph
80
H2, Pd/C
MeOH, rt
84%
FMocHN
O
OH
Ph
81
Scheme 15  : Kihlberg and Linusson's synthesis of a Gly-Phe isostere
R
N S tBu
O
CO2Et
CF3TMS/TBAT
THF
-55 to -20 oC
N S tBu
O
CO2Et
R
9 examples
Yield : 52-86%
dr : >20:1
82 83
R=H
NaBH4, THF
-78 oC, 80%
HN S tBu
O
CO2Et
84, dr : >20:1
HCl
EtOH
82%
NH2
CO2Et
85
Scheme 16  : Fustero and Barrio's synthesis of an indane δ-amino acid
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5. Synthesis via Enantioselective Catalytic Methods 
Asymmetric catalysis - perhaps the most versatile and varied 
method of enantioselective synthesis - has been employed 
numerous times in the synthesis of enantiopure δ-amino acids 
and their analogues. Transition metal-based coordination 
complexes with chiral ligands are commonly utilised for this 
purpose, a wonderful recent example of which is given by Yin 
and co-workers in the direct asymmetric vinylogous Mannich-
type reaction using a copper(I) complex (Scheme 18).30 In this 
study a range of chiral phosphines were studied, but it was (R)-
DTBM-SEGPHOS that was ultimately shown to be optimal. 
Although no real transition state is proposed, the bulky ligand 
and substituents of the pyrazole are thought to block addition of 
the acyl imine to the α-site (see box in scheme). Fascinatingly, 
this methodology was also able to be applied to the bisvinylogous 
Mannich-type reaction which led to ζ-amino acid precursors. 
 
In a similar way, the Feng group at Sichuan University 
reported an asymmetric three-component vinylogous Mannich 
reaction catalysed by a chiral scandium complex.31 Benzaldehyde 
94, aminophenol 94 and silyl dienol ether 96 were combined in 
the presence of Sc(OTf)3 and the chiral ligand 97, forming the δ-
amino acid analogue 98. A substrate scope was carried out, with 
a series of aromatic aldehydes investigated and the corresponding 
range of Mannich products obtained in comparative yields (≥ 
90%) and enantiomeric excesses (≥ 80%).  
 
Nugent and Yue developed an asymmetric hydrogenation of 
3-alkylidenelactams – potential precursors to δ2-amino acids.32 
Improving upon work carried out by researchers at Merck,33 the 
pair used an assortment of iridium, rhodium and ruthenium 
catalysts, screening a set of 32 chiral phosphine ligands. High 
conversions and enantioselectivities were found for the 
asymmetric hydrogenation of valerolactam 99 with a variety of 
metal/ligand combinations - the use of an Iridium catalyst 
bearing the BDPP ligand giving the best result (100% 
conversion, 91% e.e). Comparative results were then found for a 
range of 3-alkylidenelactam substrates, including both aromatic 
and aliphatic examples (Scheme 13). 
 
Organocatalytic methods have also been employed in the 
synthesis of δ-amino acids. For example, Schneider and co-
worker, reacted aldimine 101 with TBS-substituted dienolate 102 
in the presence of the chiral phosphoric acid catalyst 103, 
forming the Mannich product 104 in a high yield with good 
enantioselectivity.34 The reaction proved viable for a range of 
aromatic aldimines (Scheme 21).  
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Scheme 17  : Enders use of a hydrazide auxiliary leads to a stereoselective reaction
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Scheme 18  : Yin and co-workers' direct asymmetric vinylogous Mannich-type 
reaction using a copper(I) complex
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Scheme 19 : Feng's synthesis of δ5-amino acid analogues via a scandium 
catalysed Mannich reaction
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Scheme 21 : Schneider's synthesis of δ-amino acid analogues via  a 
phosphoric acid catalysed Mannich reaction
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List and co-workers have also developed a vinylogous 
Mukaiyama-Mannich process in the synthesis of δ-amino-β-
ketoesters 108 using disulfonimide organocatalyst 107.35 A large 
range of N-Boc-imines 105 were utilized and the yields and 
selectivities were largely excellent (Scheme 22). However, the 
one nonaryl system that led to product suffered a much poorer 
selectivity. 
 
An approach which involves the organocatalytic formation of 
γ-amino acids followed by Wittig homologation in the generation 
of cyclic δ-Amino acid precursors as dipeptide mimcs is 
presented by Hanessian and co-workers,36 with the ultimate aim 
of incorporating these into potentially therapeutic 
peptidomimetics. The group provide several synthetic routes in 
order to access the target compounds, one of which includes an 
organocatalytic component. Addition of 1-nitropropane to 2-
cyclohexenone 109 in the presence of the amino acid D-proline 
gave adduct 110 with good enantioselectivity (89% e.e), but with 
poor diasteresoselectivity (~31%). With the required 
stereochemistry now implemented, the synthesis was continued 
and the target compound 113, a δ2,4,5-amino acid formed in a total 
of 5 steps.  
 
One last organocatalytic example comes from our own group 
in the asymmetric synthesis of δ3-amino acids.37In this work, we 
developed a bifunctional cupreine catalyzed cyclopropanation 
between cyanosulfone 114 and bromomalonate system 115 
(Scheme 24). Following the cyclopropane synthesis, a radical 
desulfonylation leads to cyclopropanation ring opening and 
ultimately to malonate 118. Saponification followed by 
decarboxylation and reduction then led to the δ3-amino acid. To 
the best of our knowledge this represents the most expedient 
asymmetric route to these δ3-amino acid compounds currently 
known. 
 
Conclusions 
Methods towards the synthesis of δ-amino acid systems are far 
less prevalent that those of shorter ones. Those that have been 
described tend to lean towards δ2 or δ5 systems. Nevertheless, 
various approaches from each class of asymmetric reaction are 
known and offer good scope depending on the target required. Of 
particular potential are the catalytic methods which show great 
promise towards the synthesis of δ3 as well as δ5 systems. 
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